Literature DB >> 19941102

Review of human DC subtypes.

Xinsheng Ju1, Georgina Clark, Derek N J Hart.   

Abstract

Dendritic cells (DC) are critical to the induction and regulation of the innate and adaptive immune responses. They have been implicated in the pathogenesis of many autoimmune and chronic inflammatory diseases as well as contributing to the development of tumours by their lack of appropriate function. As such, understanding human DC biology provides the insight needed to develop applications for their use in the treatment of diseases. Currently, studies on mouse DC outnumber those on human cells; however, the comparison between mouse and human models has been somewhat misleading due to the basic biological and practical differences between the two models. In this review, we summarise the current understanding of human DC subtypes by describing the phenotype of the populations and how this relates to function. We also hope to clarify the differences in nomenclature between the human and mouse models that have arisen by way of the different experimental models.

Entities:  

Mesh:

Year:  2010        PMID: 19941102     DOI: 10.1007/978-1-60761-421-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

1.  Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection.

Authors:  Jessica R Loughland; Gabriela Minigo; Julie Burel; Peta E Tipping; Kim A Piera; Fiona H Amante; Christian R Engwerda; Michael F Good; Denise L Doolan; Nicholas M Anstey; James S McCarthy; Tonia Woodberry
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 2.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 3.  The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

Authors:  David A Reardon; Duane A Mitchell
Journal:  Semin Immunopathol       Date:  2017-01-30       Impact factor: 9.623

Review 4.  The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Authors:  Changjin Yuan; Guanhua Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2012-05

Review 5.  Standardizing immunophenotyping for the Human Immunology Project.

Authors:  Holden T Maecker; J Philip McCoy; Robert Nussenblatt
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

Review 6.  Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies.

Authors:  Frank R Brennan; Laura Dill Morton; Sebastian Spindeldreher; Andrea Kiessling; Roy Allenspach; Adam Hey; Patrick Y Muller; Werner Frings; Jennifer Sims
Journal:  MAbs       Date:  2010-05-23       Impact factor: 5.857

7.  Role of dendritic cells in cardiovascular diseases.

Authors:  Yi Zhang; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

8.  Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.

Authors:  Victoria M Velazquez; Huiming Hon; Chris Ibegbu; Stuart J Knechtle; Allan D Kirk; Arash Grakoui
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

9.  Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.

Authors:  Annabell Bachem; Steffen Güttler; Evelyn Hartung; Frédéric Ebstein; Michael Schaefer; Astrid Tannert; Abdulgabar Salama; Kamran Movassaghi; Corinna Opitz; Hans W Mages; Volker Henn; Peter-Michael Kloetzel; Stephanie Gurka; Richard A Kroczek
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

10.  High expression of CD11c indicates favorable prognosis in patients with gastric cancer.

Authors:  Yuan Wang; Bin Xu; Wen-Wei Hu; Lu-Jun Chen; Chang-Ping Wu; Bin-Feng Lu; Yue-Ping Shen; Jing-Ting Jiang
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.